DAIC

MARCH 31, 2025

tim.hodson Mon, 03/31/2025 - 16:38 March 29, 2025 Anthos Therapeutics, Inc., 2025 If you enjoy this content, please share it with a colleague presented two new analyses from itsAZALEA-TIMI 71 study at the American College of Cardiology Annual Scientific Session (ACC.25) 2021 4 Hsu et al. J Am Coll Cardiol. J Thromb Haemost.

Atrial Fibrillation 52

Atrial Fibrillation BMI General Cardiology Thrombosis 52

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP143-AWP143, February 1, 2025. Introduction:The majority of patients with cerebral venous thrombosis (CVT) achieve functional independence (modified Rankin Score [mRS] 0-2), although many continue to experience residual symptoms that negatively impact quality of life.

Thrombosis 40

Thrombosis Stroke Strokes Outcomes 40

Circulation

APRIL 6, 2025

Circulation, Volume 151, Issue 14 , Page e922-e922, April 8, 2025.

Thrombosis 45

Thrombosis Atherosclerosis Circulation 45

Cardiometabolic Health Congress

NOVEMBER 25, 2024

On-demand access is available now and will remain open until December 2025. Dyslipidemia, Atherosclerosis & Thrombosis: Explore non-statin therapies, strategies for managing hypertriglyceridemia, and new guidance on lipoprotein(a) management. When Will It Be Available? Ready to Access CMHC On-Demand?

CME 52

CME Obesity Certification Education 52

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATMP85-ATMP85, February 1, 2025. Introduction:Neonatal deep medullary vein (DMVT) is an increasingly recognized etiology of brain injury in term and preterm infants.

Thrombosis 40

Thrombosis Hemorrhage Congenital Outcomes 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATMP96-ATMP96, February 1, 2025. Direct oral anticoagulants (DOACs) are approved in many countries for the treatment and prevention of pediatric venous thrombosis but its use in pediatric arterial thrombosis is less established. Data was de-identified and SAS 8.3 was used for analysis.

Pediatrics 40

Pediatrics Stroke Strokes Thrombosis 40

Stroke Journal

NOVEMBER 27, 2024

Stroke, Volume 56, Issue 1 , Page 5-13, January 1, 2025. BACKGROUND:Lack of a dedicated thrombectomy device for cerebral venous thrombosis hinders the recanalization ability of endovascular treatment (EVT). Novel NiTi-braided stent retriever (Venous-TD) is a dedicated venous sinus thrombectomy device.

Thrombosis 40

Thrombosis Stent Stents Hemorrhage 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATMP116-ATMP116, February 1, 2025. Additionally, db/db mice treated with db-gut-EVs exhibited increased cerebral vascular thrombosis (182 vs 112 Fibrin+ vessels/mm2in saline, p<0.05, n=5/group), whereas db/db mice treated with dm-gut-EVs showed a reduction of thrombosis (50.5

Diabetes 40

Diabetes Thrombosis Stroke Strokes 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP355-AWP355, February 1, 2025. The change in thrombosis only occurred when mice were pre-exposed to red light. Furthermore, red light had no effect on thrombosis in blind Vsx2orJ/J mice. Introduction:Variations in light exposure are associated with changes in inflammation.

Stroke 40

Stroke Strokes Thrombosis Outcomes 40

DAIC

FEBRUARY 18, 2025

tim.hodson Tue, 02/18/2025 - 16:41 Feb. The dataset suggests tracking clinic-reported outcome measures at six months within the first year after diagnosis and annually thereafter, and patient-reported outcomes annually, with more frequent tracking advised for patients who undergo either a surgical or transcatheter procedure.

Heart Valves 52

Heart Valves Quality of Life Cardiothoracic Outcomes 52

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP260-AWP260, February 1, 2025. L), intravenous thrombolysis was associated with a reduced number of thrombectomy device passes.Conclusions:Fibrinogen plays a significant role in facilitating thrombosis and the occurrence of LVOS in patients with ICAS.

Atherosclerosis 40

Atherosclerosis Stroke Strokes Atrial Fibrillation 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP366-ATP366, February 1, 2025.

Stroke 40

Stroke Strokes Thrombosis 40

Stroke Journal

JANUARY 26, 2025

Stroke, Volume 56, Issue 2 , Page 527-532, February 1, 2025. Neutrophil extracellular traps (NETs), associated with poor outcomes and reperfusion resistance, contribute to thrombosis. Neutrophil extracellular traps (NETs), associated with poor outcomes and reperfusion resistance, contribute to thrombosis.

Hemorrhage 40

Hemorrhage Stroke Strokes Thrombosis 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP7-ATP7, February 1, 2025. Introduction:Venous thromboembolism (VTE)manifesting as deep vein thrombosis (DVT) and pulmonary embolus (PE) and arterial thromboembolism (ATE) manifesting as acute ischemic stroke (AIS) result in ~1 million US deaths annually.

Thrombosis 40

Thrombosis Pulmonary Stroke Strokes 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP201-ATP201, February 1, 2025. Background:Patients with intracerebral hemorrhage (ICH) are known to have a higher risk of venous thromboembolism (VTE) than patients with acute ischemic stroke, but the factors underlying this difference have not been clearly identified.

Hemorrhage 40

Hemorrhage Risk Factors Thrombosis Academic 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ADP36-ADP36, February 1, 2025. All patients had headache, and funduscopic examination demonstrated papilledema for all patients.

Stents 40

Stents Stent Stenosis Angioplasty 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP134-AWP134, February 1, 2025. Introduction:Stroke is a leading cause of maternal morbidity and mortality, and hemorrhagic strokes account for up to half of these cases. Prior studies in non-maternal populations demonstrated that 9% of strokes are missed at initial ED presentation.

Stroke 40

Stroke Strokes Hemorrhage Thrombosis 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWMP59-AWMP59, February 1, 2025. Background and Purpose:External counterpulsation (ECP) is a novel noninvasive method used to improve the perfusion of vital organs, which may benefit ischemic stroke patients.

Stroke 40

Stroke Strokes Hemorrhage Thrombosis 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP67-ATP67, February 1, 2025. Topics covered included early recognition, acute management, hemorrhagic stroke, cerebral venous sinus thrombosis (CVST), etc. The challenge often is how to continue to meet the education requirements in an effective and timely format.

Education 40

Education Stroke Strokes Certification 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATMP43-ATMP43, February 1, 2025. Background:Disparities in anticoagulation therapy, driven by race, age, and insurance status, affect access to direct oral anticoagulants (DOACs). Patients were drawn from neurology, cardiology, and other services.

Atrial Fibrillation 40

Atrial Fibrillation Thrombosis Nursing Embolism 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATMP16-ATMP16, February 1, 2025. Elevated levels of Lp(a) are an independent and causal risk factor for atherosclerotic cardiovascular diseases through mechanisms associated with increased atherogenesis, inflammation, and thrombosis.

Stroke 40

Stroke Strokes Academic Risk Factors 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATMP117-ATMP117, February 1, 2025. VWF traps platelets, and excessive VWF activation leads to thrombosis. Introduction:Despite timely recanalization, some ischemic stroke patients treated with endovascular thrombectomy experience persistent neurological deterioration.

Stroke 40

Stroke Strokes Thrombosis Outcomes 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page A151-A151, February 1, 2025. Eligible patients were between ages 18-50 years, with a confirmed diagnosis of arterial ischemic stroke (AIS), intracerebral hemorrhage (ICH), subarachnoid hemorrhage (SAH) or cerebral venous thrombosis (CVT) between 01/01/2012 and 12/31/2021.

Stroke 40

Stroke Strokes Hemorrhage Thrombosis 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP39-ATP39, February 1, 2025. None of the patients developed tissue/neurovascular injury or deep vein thrombosis. Background:Cerebral small vessel disease (CSVD) is a leading cause of vascular cognitive impairment (VCI). vs once-daily:1.6, mL, 95%CI -0.54-0.13).

Blood Pressure 40

Blood Pressure Thrombosis Outcomes Stroke 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATMP111-ATMP111, February 1, 2025. Introduction:VWF is an endothelial protein with known roles in hemostasis and thrombosis. We previously demonstrated abnormal deposition of VWF in themurallayer of leptomeningeal collateral arterioles (LMCs) during flow-induced outward remodeling.

Arterioles 40

Arterioles Thrombosis Stroke Strokes 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP328-AWP328, February 1, 2025. Adverse vascular outcomes used as endpoints include acute ischemic stroke, acute myocardial infarction, deep vein thrombosis/pulmonary embolism, AF, and carotid artery dissection.A Patients with any adverse vascular outcomes before the index ECG were excluded.

Atrial Fibrillation 40

Atrial Fibrillation Outcomes Coronary Artery Disease Myocardial Infarction 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP364-AWP364, February 1, 2025. proposed an innovative thromboembolic stroke model in mice where murine thrombin is injected into the M2 segment of the middle cerebral artery (MCA) to induce arterial thrombosis. Introduction:In 2007, Orset et al.

Pharmacology 40

Pharmacology Stroke Strokes Thrombosis 40

Stroke Journal

DECEMBER 9, 2024

Stroke, Volume 56, Issue 1 , Page 190-193, January 1, 2025. BACKGROUND:The presence of antiphospholipid antibodies (aPL) has been suggested as a potential cause of moyamoya angiopathy (MMA), but this remains uncertain.

Cerebrovascular Disease 40

Cerebrovascular Disease Thrombosis Hemorrhage Stroke 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP291-AWP291, February 1, 2025.

Cancer 40

Cancer Stroke Strokes Myocardial Infarction 40

Clinical Trial Results

MARCH 29, 2025

Disclosures: TBD

Thrombosis 40

Thrombosis 40

Dr. Smith's ECG Blog

MARCH 8, 2025

Angiography was technically challenging as the patient was receiving CPR, but the cardiologist suspected acute stent thrombosis and initiated cangrelor, although no repeat angiography was able to be obtained. During the resuscitation, she received amiodarone 450 mg IV, lidocaine 100 mg IV, and magnesium 6 g IV. & Dawson, D.

Cardiomyopathy 75

Cardiomyopathy Myocardial Infarction Defibrillator Bradycardia 75

Dr. Smith's ECG Blog

JANUARY 21, 2025

This was most likely acute thrombosis of a coronary artery resulting in OMI: The ECG changes were attributed to hyperkalemia. Negative trops and negative angiogram does not rule out coronary ischemia or ACS. The dye don't lie".except except when it does. Angiogram Negative, or is it?

Chest Pain 61

Chest Pain STEMI Tachycardia Myocardial Infarction 61